logo-loader

Cardiol Therapeutics signs supply agreement with Medical Cannabis by Shoppers

Published: 10:27 19 Mar 2020 EDT

Cardiol Therapeutics ((TSX: CRDL; OTCQX: CRTPF) CEO David Elsley joined Steve Darling from Proactive to discuss the company announcing a supply agreement with Medical Cannabis by Shoppers. 

Elsley discusses what this deal means for the company having a name like Shoppers associated with them, and also what is the potential market size.

Cardiol Therapeutics Receives FDA Orphan Drug Designation for Pericarditis...

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) CEO David Elsley joined Steve Darling from Proactive to share some significant news: the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for the company's lead small molecule drug candidate aimed at treating...

on 15/2/24